CBNC₂₁H₂₆O₂

Clinical Overview of Cannabinol

Moderate CB2 affinity, partial CB1 agonist (weak binding)

Key Action

Extreme biological sedative, sleep-prolonger, and bone-remineralizer.

Clinical Abstract

Cannabinol (CBN) is a natural cannabinoid produced through the aging and oxidation of THC. Exposure to ultraviolet light and oxygen converts THC molecules into CBN, reducing psychotropic properties by roughly 90% while dramatically shifting its therapeutic profile. CBN acts as a selective binder of CB2 immune gates and a mild stimulator of CB1 sleep networks. Its unique biological property is its profound muscular sedative effect. CBN relaxes contracted muscle tissue, eases nerve-induced twitching, and has been shown to stimulate osteoblasts, aiding in bone remineralization and skeletal healing.

Physiological Mechanisms of Action

Selective CB2 BindingRestricts inflammatory pain signals in deep muscle tissues.

Mild CB1 StimulationSynergizes with endogenous melatonin to signal circadian rest.

Transient Receptor Potential (TRP) ModulationDesensitizes sensory nerve endings.

Osteoblast DifferentiationPromotes the deposition of calcium in skeletal repair.

Target Clinical Indications

Severe chronic insomnia and midnight awakenings

Skeletal muscle hypertonia and severe cramps

Somatic tissue inflammation and localized swelling

Bone healing and osteoblast stimulation

Dosing & Titration Protocols (“Start Low and Go Slow”)

Administer 5mg to 10mg of CBN extract 45 minutes before sleep. To optimize the entourage mechanism, pair with a floral herbal tea. If midnight awakenings persist, raise the dosage to 15mg.

Entourage Synergies & Secondary Phyto-coupling

LinaloolCreates a powerful sleep-induction cocktail, relaxing the nervous system.

MyrceneAmplifies CBN's physical muscle-relaxant properties, unlocking deep physical rest.

THCTrace amounts of THC (0.5mg) exponentially boost CBN's sleep-promoting qualities.

Medical Study Source Citations: